164 related articles for article (PubMed ID: 33542309)
21. PKA and Ube3a regulate SK2 channel trafficking to promote synaptic plasticity in hippocampus: Implications for Angelman Syndrome.
Sun J; Liu Y; Zhu G; Cato C; Hao X; Qian L; Lin W; Adhikari R; Luo Y; Baudry M; Bi X
Sci Rep; 2020 Jun; 10(1):9824. PubMed ID: 32555345
[TBL] [Abstract][Full Text] [Related]
22. Decreased rabphilin 3A immunoreactivity in Alzheimer's disease is associated with Aβ burden.
Tan MG; Lee C; Lee JH; Francis PT; Williams RJ; Ramírez MJ; Chen CP; Wong PT; Lai MK
Neurochem Int; 2014 Jan; 64():29-36. PubMed ID: 24200817
[TBL] [Abstract][Full Text] [Related]
23. Presynaptic congenital myasthenic syndrome with altered synaptic vesicle homeostasis linked to compound heterozygous sequence variants in RPH3A.
Maselli RA; Vázquez J; Schrumpf L; Arredondo J; Lara M; Strober JB; Pytel P; Wollmann RL; Ferns M
Mol Genet Genomic Med; 2018 May; 6(3):434-440. PubMed ID: 29441694
[TBL] [Abstract][Full Text] [Related]
24. The HECT E3 Ligase E6AP/UBE3A as a Therapeutic Target in Cancer and Neurological Disorders.
Owais A; Mishra RK; Kiyokawa H
Cancers (Basel); 2020 Jul; 12(8):. PubMed ID: 32751183
[TBL] [Abstract][Full Text] [Related]
25. Angelman syndrome: advancing the research frontier of neurodevelopmental disorders.
Philpot BD; Thompson CE; Franco L; Williams CA
J Neurodev Disord; 2011 Mar; 3(1):50-6. PubMed ID: 21484597
[TBL] [Abstract][Full Text] [Related]
26. Rabphilin knock-out mice reveal that rabphilin is not required for rab3 function in regulating neurotransmitter release.
Schlüter OM; Schnell E; Verhage M; Tzonopoulos T; Nicoll RA; Janz R; Malenka RC; Geppert M; Südhof TC
J Neurosci; 1999 Jul; 19(14):5834-46. PubMed ID: 10407024
[TBL] [Abstract][Full Text] [Related]
27. Physical and functional interaction of rabphilin-3A with alpha-actinin.
Kato M; Sasaki T; Ohya T; Nakanishi H; Nishioka H; Imamura M; Takai Y
J Biol Chem; 1996 Dec; 271(50):31775-8. PubMed ID: 8943213
[TBL] [Abstract][Full Text] [Related]
28. Structural basis of Rab effector specificity: crystal structure of the small G protein Rab3A complexed with the effector domain of rabphilin-3A.
Ostermeier C; Brunger AT
Cell; 1999 Feb; 96(3):363-74. PubMed ID: 10025402
[TBL] [Abstract][Full Text] [Related]
29. The Angelman Syndrome protein Ube3A regulates synapse development by ubiquitinating arc.
Greer PL; Hanayama R; Bloodgood BL; Mardinly AR; Lipton DM; Flavell SW; Kim TK; Griffith EC; Waldon Z; Maehr R; Ploegh HL; Chowdhury S; Worley PF; Steen J; Greenberg ME
Cell; 2010 Mar; 140(5):704-16. PubMed ID: 20211139
[TBL] [Abstract][Full Text] [Related]
30. Imprinting effects of UBE3A loss on synaptic gene networks and Wnt signaling pathways.
Lopez SJ; Laufer BI; Beitnere U; Berg EL; Silverman JL; O'Geen H; Segal DJ; LaSalle JM
Hum Mol Genet; 2019 Nov; 28(22):3842-3852. PubMed ID: 31625566
[TBL] [Abstract][Full Text] [Related]
31. Phosphorylation of Rabphilin-3A, a putative target protein for Rab3A, by cyclic AMP-dependent protein kinase.
Numata S; Shirataki H; Hagi S; Yamamoto T; Takai Y
Biochem Biophys Res Commun; 1994 Sep; 203(3):1927-34. PubMed ID: 7945346
[TBL] [Abstract][Full Text] [Related]
32. Phosphorylation of rabphilin-3A by Ca2+/calmodulin- and cAMP-dependent protein kinases in vitro.
Fykse EM; Li C; Südhof TC
J Neurosci; 1995 Mar; 15(3 Pt 2):2385-95. PubMed ID: 7891174
[TBL] [Abstract][Full Text] [Related]
33. The Autism and Angelman Syndrome Protein Ube3A/E6AP: The Gene, E3 Ligase Ubiquitination Targets and Neurobiological Functions.
Khatri N; Man HY
Front Mol Neurosci; 2019; 12():109. PubMed ID: 31114479
[TBL] [Abstract][Full Text] [Related]
34. HAP1 is an in vivo UBE3A target that augments autophagy in a mouse model of Angelman syndrome.
Wang T; Wang J; Wang J; Mao L; Tang B; Vanderklish PW; Liao X; Xiong ZQ; Liao L
Neurobiol Dis; 2019 Dec; 132():104585. PubMed ID: 31445164
[TBL] [Abstract][Full Text] [Related]
35. Adult
Rotaru DC; van Woerden GM; Wallaard I; Elgersma Y
J Neurosci; 2018 Sep; 38(37):8011-8030. PubMed ID: 30082419
[TBL] [Abstract][Full Text] [Related]
36. Heterotetramer formation of prenylated Rab3A with two Rabphilin-3A molecules.
Takahashi K; Sasaki T; Takai Y
Biochem Biophys Res Commun; 1995 Dec; 217(3):979-86. PubMed ID: 8554624
[TBL] [Abstract][Full Text] [Related]
37. UBE3A: An E3 Ubiquitin Ligase With Genome-Wide Impact in Neurodevelopmental Disease.
Lopez SJ; Segal DJ; LaSalle JM
Front Mol Neurosci; 2018; 11():476. PubMed ID: 30686997
[TBL] [Abstract][Full Text] [Related]
38. From UBE3A to Angelman syndrome: a substrate perspective.
Sell GL; Margolis SS
Front Neurosci; 2015; 9():322. PubMed ID: 26441497
[TBL] [Abstract][Full Text] [Related]
39. The role of ubiquitin ligase E3A in polarized contact guidance and rescue strategies in UBE3A-deficient hippocampal neurons.
Tonazzini I; Van Woerden GM; Masciullo C; Mientjes EJ; Elgersma Y; Cecchini M
Mol Autism; 2019; 10():41. PubMed ID: 31798818
[TBL] [Abstract][Full Text] [Related]
40. UBE3A-mediated p18/LAMTOR1 ubiquitination and degradation regulate mTORC1 activity and synaptic plasticity.
Sun J; Liu Y; Jia Y; Hao X; Lin WJ; Tran J; Lynch G; Baudry M; Bi X
Elife; 2018 Jul; 7():. PubMed ID: 30020076
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]